Distinguishing B12-related acne from other causes can be challenging in clinical practice
Has SAHPRA taken action against compounded GLP-1 products
Multiple factors drive this: physician switching inertia, patient stabilization concerns, formulary contracting complexity, and the fact that most biosimilar approvals require separate prescriber actions rather than automatic pharmacy substitution [10]
Finally, medication exposure was inferred from prescription records and may not reflect actual adherence
Chronic inflammation, driven by the overactivation of glial cells, specifically microglia and astrocytes, is a common pathological characteristic of most neurodegenerative diseases
The discounted medications are expected to be in pharmacies across the country as of the beginning of June, at less than a third of the cost